TORONTO -- Celestica has invested $2.8 million recently in its healthcare division, adding capabilities and staff.

"Today's healthcare companies need partners who are prepared to invest in their success and who can deliver customized solutions to help them accelerate results," said Craig Muhlhauser, president and chief executive. "Our approach is to collaborate with our healthcare customers to deliver new and innovative supply chain solutions designed specifically for the healthcare industry of the future."

The company has invested more than $2.8 million to establish a metrology laboratory in its Suzhou, China, facility. The site also has a Class 1,000 (ISO Class 3) ISO 14644-1 certified clean room.

Celestica also named Nancy Duarte-Lonnroth director of Quality, Regulatory Affairs; Richard Rubin, director of Market Development; and Michael Sobolewski director of Sales and Business Development. 

• Prev
• Next